Royalty Pharma Donates $1,000,000 To Support Mount Sinai’s COVID-19 Patient Care and Clinical Research
Royalty Pharma today announced a charitable contribution by Royalty Pharma in the amount of $1,000,000 to Mount Sinai Health System.
Read morenews, journals and articles from all over the world.
Royalty Pharma today announced a charitable contribution by Royalty Pharma in the amount of $1,000,000 to Mount Sinai Health System.
Read moreThe Mount Sinai Hospital, the flagship hospital of Mount Sinai Health System, was listed among the nation’s top hospitals for care excellence in U.S. News and World Report, marking the fifth straight year the hospital has been listed among the top 20 in the country while landing on the distinctive “Honor Roll” list.
Read moreCenter will address psychosocial impact of COVID-19 among frontline health workers; Focus is on screening, treatment, and research
Read moreFeatures inspiring resilience stories, tips for maintaining mental and physical health, and thoughts on coping with pandemic-related stressors.
Read moreAn expert team of researchers and clinicians have been working together to design, validate, and implement an “end-to-end” clinical pathology laboratory solution that will allow for the testing of approximately several hundred people per day in order to rapidly diagnose and help guide the selection of treatment and monitor disease course.
Read moreThe Diversity Innovation Hub (DIH) at the Icahn School of Medicine at Mount Sinai is among the Top 50 in Digital Health for 2020.
Read moreThe Hospital was ranked No. 14 nationally, up four spots from last year. Eight departments within the Hospital were ranked among the top 20 nationally in their specialties, up from five last year
Read more